ASP Isotopes (NASDAQ:ASPI) Sees Unusually-High Trading Volume – Should You Buy?

Shares of ASP Isotopes Inc. (NASDAQ:ASPI) saw unusually-strong trading volume on Friday . Approximately 6,861,416 shares changed hands during trading, an increase of 76% from the previous session’s volume of 3,898,939 shares.The stock last traded at $7.8180 and had previously closed at $6.44.

Analysts Set New Price Targets

Several research firms have recently weighed in on ASPI. Canaccord Genuity Group reissued a “buy” rating and issued a $11.00 target price on shares of ASP Isotopes in a research report on Monday, November 24th. Cantor Fitzgerald initiated coverage on ASP Isotopes in a report on Thursday, December 4th. They issued an “overweight” rating and a $13.00 price objective for the company. Loop Capital set a $15.00 target price on ASP Isotopes in a research report on Monday, October 27th. Finally, Weiss Ratings reiterated a “sell (d-)” rating on shares of ASP Isotopes in a report on Monday, December 29th. Two analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $13.00.

ASP Isotopes Price Performance

The firm has a market capitalization of $842.94 million, a price-to-earnings ratio of -5.83 and a beta of 3.47. The company has a current ratio of 6.14, a quick ratio of 6.10 and a debt-to-equity ratio of 1.04. The business has a 50-day moving average price of $6.67 and a two-hundred day moving average price of $8.39.

ASP Isotopes (NASDAQ:ASPI) last issued its quarterly earnings data on Wednesday, November 19th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.05). The company had revenue of $4.89 million for the quarter, compared to the consensus estimate of $2.25 million. ASP Isotopes had a negative return on equity of 190.44% and a negative net margin of 1,259.12%. As a group, research analysts forecast that ASP Isotopes Inc. will post -0.24 EPS for the current year.

Insider Buying and Selling

In other news, CFO Heather Kiessling sold 80,000 shares of the stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $5.80, for a total value of $464,000.00. Following the completion of the transaction, the chief financial officer owned 732,500 shares of the company’s stock, valued at approximately $4,248,500. This represents a 9.85% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Also, CEO Robert Ainscow sold 8,438 shares of the company’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $6.20, for a total transaction of $52,315.60. Following the completion of the sale, the chief executive officer directly owned 1,546,255 shares of the company’s stock, valued at $9,586,781. The trade was a 0.54% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 528,091 shares of company stock valued at $3,539,245 in the last quarter. Company insiders own 14.40% of the company’s stock.

Institutional Trading of ASP Isotopes

Hedge funds and other institutional investors have recently made changes to their positions in the business. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of ASP Isotopes by 9.4% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 31,613 shares of the company’s stock valued at $148,000 after buying an additional 2,709 shares in the last quarter. Rhumbline Advisers increased its stake in ASP Isotopes by 8.2% in the 1st quarter. Rhumbline Advisers now owns 65,326 shares of the company’s stock valued at $306,000 after buying an additional 4,963 shares during the period. Exchange Traded Concepts LLC purchased a new stake in ASP Isotopes in the 2nd quarter worth approximately $9,593,000. Harbour Capital Advisors LLC acquired a new stake in shares of ASP Isotopes during the 2nd quarter valued at $232,000. Finally, Farther Finance Advisors LLC purchased a new position in shares of ASP Isotopes during the 2nd quarter valued at $707,000. 16.80% of the stock is currently owned by institutional investors.

ASP Isotopes Company Profile

ASP Isotopes Inc, a development stage advanced materials company, focuses on the production, distribution, marketing, and sale of isotopes. It engages in the production and commercialization of Molybdenum-100, a non-radioactive isotope for the medical industry; Carbon-14; and Silicon-28. The company is also developing Quantum Enrichment technology to produce Ytterbium-176, Nickel-64, Lithium 6, Lithium7, and Uranium-235. ASP Isotopes Inc was incorporated in 2021 and is headquartered in Washington, District Of Columbia.